| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
and Activin A Promote Insulin-Like Growth Factor-Binding Protein-2 and -4 Accumulation by Human Luteinizing Granulosa Cells, and Interferon-
Promotes Their Apoptosis1
Reproductive Endocrinology Center, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California 94143-0556
Address all correspondence and requests for reprints to: Dr. Robert B. Jaffe, Reproductive Endocrinology Center, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, California 94143-0556.
Insulin-like growth factor (IGF)-binding proteins (IGFBPs) antagonize
IGF and gonadotropin actions on granulosa cells. Human atretic
follicles express IGFBP-2 in granulosa cells more strongly and contain
higher levels of IGFBP-2 and IGFBP-4 than healthy follicles. We studied
the effects of interferon-
(IFN
) and activin A, which decrease
progesterone accumulation, on granulosa cell IGFBP production and
apoptosis. Conditioned media from luteinizing granulosa cells cultured
with IFN
or activin A and/or LH were subjected to ligand blotting;
northern blots of total ribonucleic acid (RNA) from these cells were
probed for IGFBP-2 and -4. Apoptosis was measured by in
situ DNA end labeling. LH decreased medium IGFBP-2 to 21% of
the control value. Although IFN
did not alter basal medium
IGFBP-2, in the presence of LH it increased IGFBP-2 3.4-fold, with
parallel changes in messenger RNA levels. Activin A also tended to
increase medium IGFBP-2 in LH-treated cultures. In conditioned medium,
IGFBP-4 was consistently decreased by LH, whereas both IFN
and
activin A increased IGFBP-4 and decreased IGFBP-4 protease activity.
Both LH and IFN
modestly stimulated IGFBP-4 messenger RNA levels.
Follistatin antagonized the action of activin A, but not that of
IFN
. IFN
, but not activin A, increased granulosa cell apoptosis.
In conclusion, IFN
produced by activated lymphocytes may decrease
endogenous IGF activity through stimulation of IGFBPs and may
promote apoptosis of granulosa-lutein cells in vivo and,
thus, luteal regression. Activin A similarly promotes IGFBP
accumulation, but it does not promote apoptosis. (J Clin
Endocrinol Metab 83: 179186, 1998)
This article has been cited by other articles:
![]() |
E. Diamanti-Kandarakis and C. Piperi Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth Hum. Reprod. Update, November 1, 2005; 11(6): 631 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
O J Ginther, E L Gastal, M O Gastal, and M A Beg In vivo effects of pregnancy-associated plasma protein-A, activin-A and vascular endothelial growth factor on other follicular-fluid factors during follicle deviation in mares Reproduction, April 1, 2005; 129(4): 489 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.M. Rivera and J.E. Fortune Development of Codominant Follicles in Cattle Is Associated with a Follicle-Stimulating Hormone-Dependent Insulin-Like Growth Factor Binding Protein-4 Protease Biol Reprod, July 1, 2001; 65(1): 112 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Klein, D. E. Battaglia, T. K. Woodruff, V. Padmanabhan, L. C. Giudice, W. J. Bremner, and M. R. Soules Ovarian Follicular Concentrations of Activin, Follistatin, Inhibin, Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-2 (IGFBP-2), IGFBP-3, and Vascular Endothelial Growth Factor in Spontaneous Menstrual Cycles of Normal Women of Advanced Reproductive Age J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4520 - 4525. [Abstract] [Full Text] |
||||
![]() |
M. José de los Santos, D. J. Anderson, C. Racowsky, and J. A. Hill Presence of Fas-Fas Ligand System and Bcl-2 Gene Products in Cells and Fluids from Gonadotropin-Stimulated Human Ovaries1 Biol Reprod, December 1, 2000; 63(6): 1811 - 1816. [Abstract] [Full Text] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |